Detailed view for PVX_092275

Basic information

TDR Targets ID: 270337
Plasmodium vivax, apical membrane antigen 1

Source Database / ID:  PlasmoDB 

pI: 7.4035 | Length (AA): 562 | MW (Da): 64477 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1

Druggability Group : DG5

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF02430   Apical membrane antigen 1

Gene Ontology

Mouse over links to read term descriptions.
GO:0016020   membrane  
GO:0009405   pathogenesis  

Metabolic Pathways

Malaria (KEGG)

Structural information

Modbase 3D models:

There are 4 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
43 475 1w8k (A) 43 475 99.00 0 1 1.66 0.03
53 383 1z40 (A) 108 438 62.00 0 1 1.28 -0.56
43 475 1w8k (A) 43 475 99.00 0 1 1.67286 -0.12
52 397 4uv6 (A) 52 397 83.00 0 1 1.60136 -1.1

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

  • 1HN6:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 1W81:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 1W8K:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 1YXE:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 1Z40:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 2J4W:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 2J5L:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 2Q8A:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 2Q8B:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 2Z8V:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 2Z8W:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date
  • 5NQG:
  • Resolution Method # Atoms # Residues Dep. Date Pub. Date Mod. Date

Expression

Upregulation Percent Ranking Stage Dataset
Upper 80-100% percentile intraerythrocytic - 36 hs, intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. Zhu L
Upregulation Percent Ranking Stage Dataset
Mid 40-60% percentile intraerythrocytic - 12 hs, intraerythrocytic - 30 hs. Zhu L
Upregulation Percent Ranking Stage Dataset
Lower 0-20% percentile intraerythrocytic - 6 hs, intraerythrocytic - 18 hs, intraerythrocytic - 24 hs. Zhu L
Show/Hide expression data references
  • Zhu L New insights into the Plasmodium vivax transcriptome using RNA-Seq.

Orthologs

Ortholog group members (OG5_147452)

Species Accession Gene Product
Babesia bovis BBOV_IV011230   apical membrane antigen 1
Neospora caninum NCLIV_064590   apical membrane antigen, putative
Plasmodium berghei PBANKA_0915000   apical membrane antigen 1
Plasmodium falciparum PF3D7_1133400   apical membrane antigen 1
Plasmodium knowlesi PKNH_0931500   apical membrane antigen 1
Plasmodium vivax PVX_092275   apical membrane antigen 1
Plasmodium yoelii PY01581   apical membrane antigen-1
Toxoplasma gondii TGME49_300130   apical membrane antigen 1 domain-containing protein
Theileria parva TP01_0650   apical membrane antigen 1, putative

Essentiality

PVX_092275 has one or more orthologs with essentiality data
Gene/Ortholog Organism Phenotype Source Study
TGME49_300130 Toxoplasma gondii Probably non-essential sidik
Show/Hide essentiality data references
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.


Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Species Known druggable target Linked compounds Reference
Plasmodium falciparum apical membrane antigen 1 Compounds References
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets

Obtained from network model

Ranking Plot


Putative Drugs List


Compound Raw Global Species
0.034 1 1
0.0055 0.3297 1
0.0283 0.3355 1
0.0283 0.3606 1

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier PVX_092275 (Plasmodium vivax), apical membrane antigen 1
Title for this comment
Comment